Alexia Flangini
Neurology with Special Qualifications in Child Neurology · Urbana, ILNPI 1023457181
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by UCB, Inc. at 24.3% of the total. Reporting peaked in 2022 at $1,758 and has fallen 78.8% since, to $374 in 2025.
Across 148 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$997
- Livanova USA, Inc.$845
- Jazz Pharmaceuticals Inc.$425
- Sunovion Pharmaceuticals Inc.$299
- Neurelis, Inc.$258
- Greenwich Biosciences, Inc.$238
- plus $1K from 19 others
What the payments were for
- Travel & lodging$3138%
- Food & beverage$3,79492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 39 | $997 |
| Livanova USA, Inc. | 5 | $845 |
| Jazz Pharmaceuticals Inc. | 12 | $425 |
| Sunovion Pharmaceuticals Inc. | 35 | $299 |
| Neurelis, Inc. | 7 | $258 |
| Greenwich Biosciences, Inc. | 5 | $238 |
| Eisai Inc. | 9 | $177 |
| Upsher-smith Laboratories LLC | 4 | $127 |
| Immedica Pharma US, Inc. | 4 | $113 |
| Sumitomo Pharma America, Inc. | 7 | $89 |
| Zogenix Inc. | 1 | $84 |
| Acadia Pharmaceuticals Inc | 3 | $71 |
| Novartis | 2 | $52 |
| Catalyst Pharmaceuticals, Inc. | 2 | $50 |
| AbbVie | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Genentech USA, Inc. | 1 | $26 |
| NS Pharma, Inc. | 1 | $25 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| SK Life Science, Inc. | 1 | $23 |
| Aucta Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Medtronic | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$759
- VALTOCO$107
How this compares
$4,106 in reported general payments places this provider in the 70th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Urbana
- Douglas NordliChicago$621K
- Nancy KuntzChicago$503K
- Ryan CoatesOak Lawn$163K
- Vamshi RaoChicago$124K
- Takijah HeardEvanston$94K
- John MillichapChicago$84K
- Sookyong KohChicago$60K
- M KaterjiNaperville$52K
- Charles MarcuccilliBurr Ridge$42K
- Elizabeth Berry-KravisChicago$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.